Parametrica Management Ltd - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 124 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.

Quarter-by-quarter ownership
Parametrica Management Ltd ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$433,000
+104.2%
9,754
-40.4%
0.47%
+113.1%
Q1 2017$212,000
+61.8%
16,367
+51.3%
0.22%
-38.8%
Q3 2016$131,000
-55.1%
10,817
-63.4%
0.36%
-83.7%
Q2 2014$292,000
+117.9%
29,578
+143.9%
2.21%
+32.2%
Q3 2013$134,00012,1251.67%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders